Arm 1 | Arm 2 | |
---|---|---|
Participants, N | 19 | 15 |
Mean age, years | 51 | 56 |
Females, n | 11 | 8 |
Males, n | 8 | 7 |
Complaints | ||
Mean duration at intake, weeks | 8 | 6 |
First episode, n | 2 | 3 |
More than one episode, n | 4 | 2 |
Episode every year, n | 13 | 10 |
Mean VAS score max: pain, itch, mm | 29 | 25 |
Mean VAS score disability, mm | 21 | 13 |
Smoking, n | 3 | 2 |
Comorbidity | ||
Diabetes, n | 2 | 0 |
Peripheral arterial disease, n | 1 | 0 |
Raynaud’s phenomenon, n | 5 | 3 |
Relevant medication use | ||
Beta-blocker, n | 0 | 1 |
Nicotine replacement drug, n | 0 | 0 |
Acetylsalicylic acid, n | 1 | 0 |
ACE or A2 inhibitor, n | 2 | 0 |
A2 = angiotensin. ACE = angiotensin-converting enzyme. VAS = visual analogue scale.